Institut Mérieux strengthens its commitment to medicine and global public health

16-Dec-2010 - France

One year after reinstating the name of Institut Mérieux for the family holding devoted to industrial biology, Alain Mérieux and the management teams of the companies, bioMérieux, Transgene, Mérieux Nutrisciences and Mérieux Développement, have presented the actions implemented within the scope of their innovation and international development strategy with:

- the structuring of a food safety/nutrition hub based around Mérieux NutriSciences, completing and supporting the diagnostic and therapeutic areas covered by Institut Mérieux

- the Group's innovation policy with, in particular, the first holdings by its investment company, Mérieux Développement

- the development of biology accessible to all with the creation of IMAccess, a not-for-profit company devoted to diagnostics in developing countries.

"Institut Mérieux has undergone considerable changes to address the new global challenges in medicine and public health. The arrival of Jean-Luc Bélingard as Président Directeur Général of bioMérieux and Vice-President of Institut Mérieux will enable me to devote more time to Institut Mérieux and the Mérieux foundations", stated Alain Mérieux. "Now, more than ever, scientific innovation, multidisciplinary approaches and international development are at the heart of our strategy. In an ever-changing healthcare environment, with infectious disease representing a constant threat, the emergence of new risks associated with food and now better known interactions between infectious diseases, cancers and nutrition, we have made sure we have new resources to achieve our long-term targets. The structuring of a nutrition/health hub, which is highly complementary to our therapeutic and diagnostic activities, is a strong example. Our innovation strategy is also taking form with Mérieux Développement and a stronger international network of scientific experts. Finally, IMAccess aims to offer a complementary approach to conventional models, to make quality biology and diagnostics accessible to the greatest number and thus combat infectious diseases, with no borders between North and South."

https://www.bionity.com/en/news/127277/institut-merieux-strengthens-its-commitment-to-medicine-and-global-public-health.html